BD Launches Next Generation Blood-Based Monitoring Solution Providing AI-Driven Clinical Decision Support

Becton, Dickinson, and Company (BD), a medical technology company, has launched a new advanced hemodynamic (blood-based) monitoring platform and device, called the HemoSphere Alta™, to monitor blood pressure instability during surgical procedures. The HemoSphere Alta platform uses predictive, artificial intelligence (AI)-based algorithms to help clinical professionals optimize blood flow.

The platform includes a 15-inch, high-resolution, customizable touchscreen monitor display, split-screen views, and a design that minimizes disruptive pop-ups. Voice and gesture command features help maintain sterility and allow hands-free interaction, such as silencing alarms and switching views. The platform includes the following monitoring . . .